l.Le Dourain N, Kalcheim C. The Neural Crest. 2nd ed. Developmental and cell biology series No 36. Cambridge, UK: Cambridge University Press; 2009. 2. Kukesa PM, Bayley CM, Kasemeire-Kulesa JC, et al. Cra-nial neural crest migration: new rules for an old road. Dev Biol2010;15:543-554. 3. Scherer SS. The biology and pathobiology of Schwann cells. Curr Opin Neurol1997;10:386-397. 4. Lai C. Peripheral glia: Schwann cells in motion. Curr Biol 2005; 15:332-334. 5. Nonaka D, Chiriborga L, Rubin BP. Soxl0: a pan-schwann-ian and melanocytic marker. Am] Surg Pathol2008;32: 1291-1298. 6. Graham A. Melanocyte production: dark side of the Schwann cell. Curr Biol2009;19:Rl16-Rl17. 7. Jessen KR, Mirsky R.The origin and development of glia cells in peripheral nerves. Nat Rev Neurosci 2005;6:671-682. 8. Levi-Montalcini R.The nerve growth factor and the neuro-science chess board. Prog Brain Res 2004;146:525-527. 9. Anand P. Neurotrophic factors and their receptors in human sensory neuropathies. Prog Brain Res 2004;146;477-492. 10. Schecterson LC, Bothwell M. Neurotrophin receptors: old friends with new partners. Dev Neurobiol2010;70:331-338. 11. Giger RJ, Hollis ER II, Tusznski MH. Guidance mole-cules in axon regeneration. Cold Spring Harb Perspect Biol 2010;2:12-221. 12. Tucker BA, Mearow KM. Peripheral sensory axon growth: from receptor binding to cellular signaling. Can] Neurol Sci 2008;35:551-566. 13. Madduri S, Gander B. Schwarm cell delivery of neuro-trophic factors for peripheral nerve regeneration. ] Peripher Nerv Syst 2010;15:93-103. 14. Chernousov MA, Yu WM, Chen ZL, et al. Regulation of Schwann cell function by the extracellular matrix. Glia 2008;56; 1498-1507. 15. Shy ME. Biology of peripheral inherited neuropathies: Schwann cell axonal interactions. Adv Exp Med Biol 2009;652;171-181. 16. Quintes S, Goebbels S, Saher G, et al. Neuron-glia signal-ing and the protection of axon function by Schwann cells.] Peripher Nerv Syst 2010;15;10-16. 17. Shield LK, King RHM, Thomas PK. A morphologic study of human fetal sural nerve. Acta Neuropathol 1986;70:60-70. 18. Thomas PK, Ochoa J. Microscopic anatomy of peripheral nerve fibers. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds. Peripheral Neuropathy Vol1.2nd ed. Philadelphia, PA: Saunders; 1984:34-96. 19. Sherman DL, Brophy PJ. Mechanisms of axon ensheath-ment and myelin growth. Nat Rev Neurosci 2005;6:683-690. 20. Xiao J, Kilpatrick TJ, Murray SS. The role of neurotroph-ins in the regulation of myelin development. Neurosignals 2009;17:265-276. 21. Nave K-A. Myelination and the trophic support of long axons. Nat Rev Neurosci 2010;11:275-283. 22. Shnaar RL, Lopez PH. Myelin-associated glycoprotein and its axonal receptors.] Neurosci Res 2009;87:3267-3276. 23. Reina MA, L6pezA, Villanueva MC, et al. Morfologia de los nervios perifericos, de sus cubiertas y de su vascularizaci6n. Rev Esp Anestesiol Reanim 2000;47 :464-475. 24. Geuna S, Raimondo S, Ronchi G, et al. Histology of the peripheral nerve and changes occurring during nerve regen-eration. Int Rev Neurobiol 2009;87:27-46. 25. Sloniewski P, Korejwo G, Zielinski P, et al. Measurements of the obersteiner-redlich zone of the vagus nerve and their possible clinical applications. Folia Morphol 1999;58:37-41.26. Streit A. The cranial sensory nervous system: specification of sensory progenitors and placodes. In: StemBook [Internet]. Cambridge, MA: Harvard Stem Cell Institute; 2008: 1-20. 27. Tassler PL, Dellon AL, Canoun C. Identification of elastic fibers in the peripheral nerve.] Hand Surg [Br} 1994; 19:48-54. 28. Cavanagh JG. Pathology of peripheral nerve diseases. In: Weller RO, ed. Systemic Pathology: Nervous System Muscle and Eyes. Vol 4. 3rd ed. Edinburgh: Churchill Livingstone; 1990:544-578. 29. Al-Jabri T, Garg S, Mani GV Lipofibromatous hamartoma of the median nerve.] Orthop Surg Res 2010;28:1-4. 30. Pifia-Oviedo S, Ortiz-Hidalgo C. The normal and neoplastic perineurium: a review. AdvAnat Pathol2008;15:147-164. 31. Sharghi-Namini S, Turmaine M, Meier C, et al. The struc-tural and functional integrity of peripheral nerves depends on the glial-derived signal desert hedgehog. ] Neurosci 2006;26:6364-6376. 32. Vega JA, Garcia-Suarez 0,Montano JA, et al. The Meissner and Pacinian sensory corpuscles revisited new data from the last decade. Microsc Res Tech 2009;72:299-309. 33. Goehler LE, ReIton JK, Dripps D, et al. Vagal paraganglia bind biotinylated interleukin-I receptor antagonist: a possi-ble mechanism for immune-to-brain communication. Brain Res Bull 1997;43:357-364. 34. Reina MA, Lopez A, Villanueva MC, et al. La barrera hemato-nerviosa en los nervios. Rev Esp Anestesiol Reanim 2003;50:80-86. 35. Alanne MH, Pummi K, Heape AM, et al. Tight junction proteins in human Schwann cell autotypic junctions.] His-tochem Cytochem 2009;57:523-529. 36. Folpe AL, Billings SD, McKenney JK, et al. Expression of claudin-l, a recently described tight junction-associated protein, distinguishes soft tissue perineurioma from poten-tial mimics. Am] Surg Pathol2002;26:1620-1626. 37. Cavanagh JB. Toxic and deficiency disorders. In: Weller RO, ed.Systemic Pathology: Nervous System, Muscle and Eyes. Vol 4. 3rd ed. Edinburgh: Churchill Livingstone; 1990:244-308. 38. Ahmed AM, Weller RO. The blood-nerve barrier and recon-stitution of the perineurium following nerve grafting. Neuro-patholAppl Neurobiol1979;5:469-483. 39. Weller RO. Localized hypertrophic neuropathy and hyper-trophic polyneuropathy. Lancet 1974;ii:529-593. 40. MacKeever PE. Immunohistochemistry of the nervous sys-tem. In: Dabbs DJ, ed. Diagnostic Immunohistochemistry. Philadelphia, PA: Churchill-Livingstone; 2006: 746-816. 41. Hirose T, Tani T, Shimada T, et al. Immunohistochemical demonstration of EMNGlutl-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors. Mod Pathol2003;16:293-298. 42. Yamaguchi U, Hasegawa T, Hirose T, et al. Sclerosing peri-neurioma: a clinicopathological study of five cases and diag-nostic utility of immunohistochemical staining for GLUTI. VirchowsArch 2003;443:159-163. 43. Macarenco RS, Ellinger F, Oliveira AM. Perineurioma: a distinctive and under recognized peripheral nerve sheath neoplasm. Arch Pathol Lab Med 2007;131:625-636. 44. Lee JH, Lee KG, Ryou H, et al. Significance analysis of histologic type and perineural invasion as prognostic fac-tors after curative resection of ampulla of Vater carcinoma. Hepatogastroenterology 2010;57:646-652. 45. Fogt F, Capodieci P, Loda M. Assessment of perineural inva-sion by GLUT-1 immunohistochemistry. Appl Immunohisto-chem 1995;3:194-197. 46. Ronaghy A, Yaar R, Goldberg LJ, et al. Perineurial involve-ment: what does it mean? Am] Dermatopathol20 10;32:469-476. 47. Khalifa MA, Montgomery EA, Ismiil N, et al. What are the CD34+ cells in benign peripheral nerve sheath tumors? Double immunostaining study of CD34 and S-l 00 protein. Am] Clin Pathol2000;114:123-126. 48. Maurer M, Muller M, Kobsar I, et al. Origin of pathogenic macrophages and endoneurial fibroblast-like cells in an animal model of inherited neuropathy. Mol Cell Neurosci 2003;23:351-359. 49. Bonetti B, Monaco S, Giannini C, et al. Human peripheral nerve macrophages in normal and pathological conditions.] Neural Sci 1993;118: 158-168. 50. Smithson LJ, Kawaja MD. Microglial/macrophage cells in mammalian olfactory nerve fascicles. ] Neurosci Res 2010;88:858-865. 51. Vallat JM, Vital A, Magy L, et al. An update on nerve biopsy. ] Neuropathol Exp Neurol 2009;68:833-844. 52. Ryan JJ,Klein KA, Neuberger TJ, et al. Role for the stem cell factor/KIT complex in Schwann cell neoplasia and mast cell proliferation associated with neurofibromatosis. ] Neurosci Res 1994;15:415-432. 53. Staser K, Yang FC, Clapp DW. Mast cells and the neurofi-broma microenvironment. Blood 2010;116: 157-164. 54. Esposito B, De Santis A, Monteforte R, et al. Mast cells in Wallerian degeneration: morphologic and ultrastructural changes.] Camp Neurol2002;445:199-210. 55. Hill R. Extracellular matrix remodeling in human diabetic neuropathy.] Anat 2009;21:219-225. 56. Weller RO, Cervos Navarro J. Pathology of Peripheral Nerves: APractical Approach. London: Butterworth; 1977. 57. Pifia-Oviedo S, Del Valle L, Baquera-Heredia J, et al. Imunohistochemical characterization of Renaut bodies in superficial digital nerves: further evidence supporting their perineurial cell origin. ] Peripher Nerv Syst 2009; 14: 22-26. 58. Briemberg HR. Peripheral nerve complications of medical disease. Semin Neural 2009;29:124-135. 59. Lindemuth R, Ernzerhof C, Schimrigk K. Comparative morphometry of myelinated nerve fibers in the normal and pathologically altered human sural and tibial nerve. Clin Neuropathol2002;21 :29-34. 60. Baker MD. Electrophysiology of mammalian Schwann cells. Prog Biophys Mol Biol 2002;78:83-103. 6l. Shea TB, Chan WK, Kushklev J, et al. Organizational dynamics, functions, and pathobiological dysfunctions of neurofilaments. Results Probl Cell Differ 2009;48:29-45. 62. Al-Chalabi A, Miller CC. Neurofilaments and neurological disease. Bioessays 2003;25:346-355. 63. Fainikar A, Bass PW. Critical roles for microtubules in axonal development and disease. Results Prahl Cell Differ 2009;48:47-64. 64. Morfini AG, Burns M, Binder LI, et al. Axonal transport defects in neurodegenerative diseases. ] Neurosci 2009; 14: 12776-12786. 65. Baas PW, Buster DW. Slow axonal transport and the genesis of neuronal morphology.] Neurobiol 2004;58:3-17.66. Salinas S, Schiavo G, Kremer EJ. A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins. Nat Rev Microbial 2010;8:645-655. 67. Peters A.The effects of normal aging on myelin and nerve fibers: a review.] Neurocytol2002;31:581-593. 68. Terada S. Where does slow axonal transport go? Neurosci Res 2003;47:367-372. 69. Spencer PS, Schaumburg HH, Ludolph AC. Experimental and Clinical Neurotoxicology. 2nd ed. New York, NY: Oxford University Press; 2000. 70. Katalymov LL, Glukhova NV Some characteristics of periaxonal space in myelinated nerve fibers. Dold Biol Sci 2003;388:9-1l. 7l. Nave KA, Trapp BD. Axon-glial signaling and the glial sup-port of axon function. Annu Rev Neurosci 2008 ;31: 535-56l. 72. Quarles RH. Myelin-associated glycoprotein: past, present and beyond.] Neurochem 2007;100:1431-1448. 73. Mirsky R, Jessen KR. The neurobiology of Schwarm cell. Brain Pathol 1999;9:293-311 74. Woodhoo A, Sommers L.Development of the Schwann cell lineage: from the neural crest to the myelinated nerve. Glia 2008;56: 1481-1490. 75. Weller RO, Herzog I.Schwann cell lysosomes in hyper-trophic neuropathy and in normal human nerves. Brain 1970;93:347-356. 76. Gonzalez-Martinez T, Perez-Pinera P, Diaz-Esnal B, et al. S-100 proteins in the human peripheral nervous system. Microsc Res Tech 2003;60:633-638. 77. Garavito Zv, Sutachan JJ,Muneton VC, et al. Is S-100 pro-tein a suitable marker for adult Schwann cells? In Vitro Cell Dev BiolAnim 2000;36:281-283. 78. Le Forestier N, Lescs MC, Gherardi RK. Anti-NKH-1 antibody specifically stains unmyelinated fibers and non-myelinating Schwann cell columns in humans. Neuropathol Appl Neurobiol 1993; 19: 500-506. 79. Fine SW, McCline SA, Li M. Immunohistochemical stain-ing for calretinin is useful for differentiating schwanno-mas from neurofibromas Am] Clin Pathol 2004;122:552-559. 80. Shih I-M. The role of CD146 in biology and pathology.] Pathol 1999; 189:4-1l. 81. Kawahara E, Oda Y, Ooi A, et al. Expression of glial fibrillary acidic protein in peripheral nerve sheath tumors. Am] Surg Pathol 1988; 12: 115-120. 82. Koirala S, Reddy LV, Ko CPo Roles of glia cell in the forma-tion, function and maintenance of the neuromuscular june-tion.] Neurocytol 2002;32:987-1002. 83. Oda R, Yaoi T, Okajima S, et al. A novel marker for termi-nal Schwann cells, homocysteine-responsive ER-resident protein, as isolated by a single cell PCR-differential display. Biochem Biophys Res Commun 2003;308:872-877. 84. Wewetzer K, Verdu E, Agelov DN, et al. Olfactory ensheath-ing glia and Schwann cells: two of a kind? Cell Tissue Res 2002;309:337-345. 85. Simon M, Trotter J. Wrapping it up: the cell biology of myelination. Curr Opin Neruobiol2007;17:53-540. 86. Kursula P.Structural properties of proteins specific to the myelin sheath. Amino Acids 2008;34: 175-185. 87. Spiegel I, Peles E. Cellular junctions of myelinated nerves. Mol Membr Biol 2002;19:95-10l. 88. Young P, Boussadia 0,Berger P, et al. E-cadherin is required for the correct formation of autotypic adherens junctions of the outer mesaxon but not for the integrity of myelinated fibers of peripheral nerves. Mol Cell Neurosci 2002;21 :341-531. 89. Jahn 0,Tenzer S, Werner HB. Myelin proteomics: molec-ular anatomy of an insulating sheath. Mol Neurobiol 2009;40:55-72. 90. Quarles RH. Comparison of CNS and PNS myelin pro-teins in the pathology of myelin disorders. ] Neurol Sci 2005;228: 187-189. 91. Garbay B, Heape AM, Sargueil F, et al. Myelin synthesis in the peripheral nervous system. Prog Neurobiol 2000 ;61: 26 7-304. 92. Raine CS. Multiple sclerosis and chronic relapsing EAE: comparative ultrastructural neuropathology. In: Halipike JF, Adams CWM, Tourtelotte WW, eds. Multiple Sclerosis. London: Chapman and Hall; 1983:413-460. 93. Shy ME, Garbern JY, Kamholz]. Hereditary motor and sen-sory neuropathies: a biological perspective. Lancet Neurol 2002;1:110-118. 94. Chen ZL, Strickland S. Laminin gammal is critical for Schwann cell differentiation, axon myelination, and regen-eration in the peripheral nerve.] Cell Bioi 2003;163:889-899. 95. Podratz JL, Rodriguez E, Windebank A]. Role of the extra-cellular matrix in myelination of peripheral nerve. Glia 2001;35:35-40. 96. Takashima H, Boerkoel CF, De Jonghe P, et al. Periaxin mutations cause a broad spectrum of demyelinating neu-ropathies. Ann Neurol 2002;51 :709-715. 97. Balice-Gordon RJ, Bone LJ, Scherer SS. Functional gap junctions in the Schwann cell myelin sheath. ] Cell BioI 1998; 142: 1095-1104. 98. Burton A.Absence of Cajal bands short changes Schwann cells. Lancet NeuroI2004;3:639-641. 99. Susuki K, Rasband MN. Molecular mechanisms of node of Ranvier formation. Curr Opin Cell BioI 2008;20:616-623. 100. Dzhashiashvili Y,Zhang Y,Galinska J, et al. Nodes of Ran-vier and axon initial segments are ankyrin G-dependent domains that assemble by distinct mechanisms. ] Cell Bio! 2007;117:857-870. 101. Scherer SS. Nodes, paranodes, and incisures: from form to function. Ann NY Acad Sci 1999;883: 131-142. 102. Thaxton C, Bhat M. Myelination and regional domain dif-ferentiation of the axon. Results Probl Cell Differ 2009;48: 1-28. 103. Griffin JW, Thompson W]. Biology and pathology of non-myelinating Schwarm cells. Glia 2008;56:1518-1531. 104. Gray MH, RosenbergAE, Dickersin GR, et al. Glial fibrillary acidic protein and keratin expression by benign and malig-nant nerve sheath tumors. Hum PathoI1989;20: 1089-1096. 105. Scollard DM. The biology of nerve injury in leprosy. Lepr Rev 2008;79:242-253. 106. Schmidt HG, Schmid A, Domschke W. Nerve-neuroendo-crine complexes in stomach mucosa in Zollinger-Ellison syn-drome. Pathologe 1995; 16:404-407. 107. Aubock L, Hofler H. Extraepithelial intraneural endocrine cells as starting-points for gastrointestinal carcinoids. Vir-chows Arch APatholAnat Histopathol1983;401:17-33. 108. Franke C, Gerharz CD, Bohner H, et al. Neurogenic appen-dicopathy in children. Eur] Pediatr Surg 2002; 12:28-31.109. Mayerzu Horste G, Hartung HP, Lehmann HC, et al. The immunocompetence of Schwann cells. Muscle Nerve 2008;37:3-13. 110. Bonetti B, Valdo P, Ossi G, et al. T-cell cytotoxicity of human Schwann cells: TNFalpha promotes fasL-mediated apoptosis and IFN gamma perforin-mediated lysis. Glia 2003;43:141-418. Ill. Zhang YP, Porter S, Wekerle H. Schwann cells in myasthe-nia gravis. Preferential uptake of soluble and membrane-bound AChR by normal and immortalized Schwann cells, and immunogenic presentation to AChR-specific T line lym-phocytes. Am] Pathol 1990; 136: 111-122. 112. Vedeler C, Ulvestad E, Borge L, et al. Expression of CD-59 in normal human nervous tissue. Immunology 1994;82:542-547. 113. Kieseier BC, Hartung HP, Wiendel H. Immune circuitry in the peripheral nervous system. Curr Opin Neurol 2006; 19:437-445. 114. Vucic S, Kiernan MC, Cornblath DR. Cuillain-Barre syn-drome: an update. Clin Neurosci 2009;16:733-741. 115. Hughes R. Peripheral nerve diseases: the bare essentials. Pract Neurol 2008;8:396-405. 116. Kanda T.Usefulness of sural nerve in the genomic era. Neu-ropathology 2009;29:502-508. 117. Glass JD. Wallerian degeneration as a window to peripheral neuropathy.] Neurol Sci 2004;220: 123-124. 118. Radtke C, Vog PM. Peripheral nerve regeneration: a current perspective. Eplasty 2009;12:437-442. 119. Tofaris GK, Patterson PH, Jessen KR, et al. Denervated Schwarm cells attract macrophages by secretion of leuke-mia inhibitory factor and monocyte chemoattractant protein-I in a process regulated by interleukin-6 and LIP. ] Neurosci 2002;22:6696-6703. 120. Hirata K, Kawabuchi M. Myelin phagocytosis by macro-phages and nonmacrophages during Wallerian degeneration. Microsc Res Tech 2002;57:541-547. 121. Martini R, Lopez- Vales R, David S. Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia 2008;56: 1566-1577. 122. Burnett MG, Zager EL. Pathophysiology of peripheral nerve injury: a brief review. Neurosurg Focus 2004; 16:E 1. 123. Horie H, Kadoya T, Hikawa N, et al. Oxidized galectin-I stimulates macrophages to promote axonal regeneration in peripheral nerves after axotomy. ] Neurosci 2004;24: 1873-1880. 124. Blackemore WK. Myelination, demyelination and remy-elination. In: Thomas Smith W, Cavanagh JB, eds. Recent Advances in Neuropathology. Vol 2. Edinburgh: Churchill Livingstone; 1982:53-82. 125. Lee SK, Wolfe SW. Nerve regeneration and repair. ] Am Acad Orthop Surg 2000;8:243-252. 126. Blesch A, Tuszynski MH. Nucleus hears axon's pain. Nat Med 2004;10:236-237. 127. Hanz S, Fainzilber M. Retrograde signaling in injured nerve-the axon reaction revisited.] Neurochem 2006;99:13-19. 128. Bergner AJ, Murphy SM, Anderson CR. After axotomy, sub-stance P and vasoactive intestinal peptide expression occurs in pilomotor neurons in the rat superior cervical ganglion. Neuroscience 2000;96:611-618. 129. Denny JB. Molecular mechanisms, biological actions, and neuropharmacology of the growth-associated protein GAP-43. Curr Neuropharmacol 2006;4:293-304. 130. Radtke C, Vogt PM. Peripheral nerve regeneration: a current perspective. Eplasty 2009;9:e47. 131. Camara-Lemarroy CR, Cuzman-de la Garza FJ, Fernandez-Garza NE. Molecular inflammatory mediators in peripheral nerve degeneration and regeneration. Neurinmunomodula-tion 2010;17:314-324. 132. Gordon T.The role of neurotrophic factors in nerve regen-eration. Neurosurg Focus 2009;26:E2. 133. Craner MJ, Hains BC, Lo AC, et al. Co-localization of sodium channel Nav 1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE. Brain 2004;127:294-303. 134. Frisen J, Risling M, Fried K.Distribution and axonal relations of macrophages in neuroma. Neuroscience 1993;55: 1003-1013. 135. Dyck P],Dyck PJB, Giannini C, et al. Peripheral nerves. In: Graham DI, Lantos PL, eds. Greenfield's Neuropathology London: Arnold; 2002:551-675. 136. Ramchandres S, Lisak RP. The immunopathogenesis of Guillain-Barre syndrome. Clin Adv Hematol Oncol 2010;8: 203-206. 137. Weller RO, Nester B. Early changes at the node of Ran-vier in segmental demyelination: histochemical and electron microscopic observations. Brain 1972;95:665-674. 138. Weller RO, Bruckner FE, Chamberlain MA. Rheumatoid neuropathy: a histological and electrophysiological study. ] Neurol Neurosurg Psychiatry 1970;33:592-604. 139. Parman Y Hereditary neuropathies. Curr Opin Neurol 2007;20:542-547. 140. Scherer SS, Wrabetz L. Molecular mechanisms of inherited demyelinating neuropathies. Glia 2008;56: 1578-1589. 141. Pareyson D, Marchesi C.Diagnosis, natural history, and management of Charcot-Marie-Tooth disease. Lancet Neu-rol2009;8:654-667. 142. Burgunder JM, Schols L, Beats J, et al. EFNS guidelines for the molecular diagnosis of neurogenetic disorders: moto-neuron, peripheral nerve and muscle disorders. Eur] Neurol 2010;18:207-217. 143. Reilly MM, Sht ME. Diagnosis and new treatments in genetic neuropathies. ] Neurol Neurosurg Psychiatry 2009;80: 1304-1314. 144. Ironside JW, Moss TH, Louis DN, et al. Tumours of periph-eral nerves. In: Diagnostic Pathology of Nervous System Tumours Edinburgh: Churchill Livingstone; 2002:425-464. 145. Hassouna H, Singh D. Morton's metatarsalgia: pathogen-esis, aetiology and current management. Acta Orthop Belg 2005;71 :646-655. 146. Beer TW. Reparative perineurial hyperplasia: a series of 10 cases. Am] Dermatopathol 2009;31: 50-52. 147. Jokinen CH, Ragsadele BD, Argenyi ZB. Expanding the clin-icopathologic spectrum of palisaded encapsulated neuroma. ] Cutan Pathol2010;37:43-48. 148. Kurtkaya-Yapicier 0, Scheitauer B, Woodruff JM. The pathobiologic spectrum of Schwannomas. Histol Histopathol 2003;18:925-934. 149. Mrugala MM, Batchelor TT, Plotkin SR. Peripheral and cranial nerve sheath tumors. Curr Opin Neurol2005;18:604-610. 150. Canales-Ibarra C, Magarifios G, Olsoff-Pagovich P, et al. Cutaneous sclerosing perineurioma of the digits: an uncom-mon soft tissue neoplasm. Report of a case with immunohis-tochemical analysis.] Cutan Pathol 2003;30:577-581.151. AI-Daraji WI. Granular perineurioma: the first report of a rare distinct subtype of perineurioma. Am] Dermatopathol 2008;30: 163-168. 152. Ortiz-Hidalgo C, Carbajal-Dosamantes A. Malignant peri-neurioma (malignant peripheral nerve sheath tumor, peri-neurial). Immunohistochemical study of an unusual tumor, using EMA, Glut-l and Claudin-l, as perineurial cell dif-ferentiation markers. Rev Esp Patol 2006;39: 105-111. 153. Nascimento AF, Fletcher CDM. The controversial nosol-ogy of benign nerve sheath tumors: neurofilament protein staining demonstrates intratumoral axons in many sporadic schwannomas. Am] Surg Pathol2007;3l:1363-1370. 154. Thaxton C, Lopera J, Bott M, et al. Neuregulin and laminin stimulate phosphorylation of the NF2 tumor suppressor in Schwann cells by distinct protein kinase A and p21-activated kinase-dependent pathways. Oncogene 2008;27:2705-2715. 155. Wippold FJ II, Lubner M, Perrin RJ, et al. Neuropathol-ogy for the neuroradiologist: Antoni A and Antoni B tissue paterns. A]NR Am] Neuroradiol 2007 ;28: 1633-1638. 156. de Saint Aubain Somerhausen N, Valaeys V, Geerts M, et al. Neuroblastoma-like schwannoma: a case report and review of the literature. Am] Dermatopathol 2003;25:32-34. 157. Kim YC, Park HJ, Cinn YW, et al. Benign glandular schwannoma. Br] Dermatol2001;145:834-837. 158. Laskin WB, Fetsch JF, Lasota J, et al. Benign epitheli-oid peripheral nerve sheath tumors of the soft tissues. Clinicopathologic spectrum of 33 cases. Am] Surg Pathol 2005;29:39-51. 159. Laskin WB, Fetsch JF, Miettinen M. The "neurothekeoma": immunohistochemical analysis distinguishes the true nerve sheath myxoma from its mimics. Hum Pathol2000;31: 1230-1241. 160. Scheithauer BW, Woodruff JM, Erlandson RA. Atlas of Tumor Pathology: Tumors of the Peripheral Nervous System. Third series Fascicle 24. Washington, DC: Armed Forces Institute of Pathology; 1997. 161. Suchak R, Luzar B, Bacchi CE, et al. Cutaneous neuroblas-toma-like schwannoma: a report of two cases, one with a plexiform pattern, and a review of the literature. ] Cutan Pathol2010;37:997-1001. 162. Ortiz-Hidalgo C. Jose Verocay. Verocay neurinomas and bodies and other contributions to medicine. Rev Neurol 2004;39:487-491. 163. Dingemans KP,Teeling P. Long-spacing collagen and proteogly-cans in pathologic tissue. Ultrastruct PatholI994;18:539-54 7. 164. Agaimy A, Mark] B, Kitz J, et al. Peripheral nerve sheath tumors of the gastrointestinal tract: a multicenter study of 58 patients including NF I-associated gastric shcwan-noma and unusual morphologic variants. Virchows Arch 2010;456:411-422. 165. Pytel P, Karrion T, Gong C, et al. Neoplasms with Schwann-ian differentiation express transcriptional factors known to regulate normal Schwann cell development. Int] Surg Pathol.2010;18:449-457. 166. Yen S-H, Fields KL. A protein related to glial filaments in Schwann cells. Ann NYAcad Sci 1985;455:538-551. 167. Arvanitis LD. Melanotic schwannoma: A case with strong CD34 expression, with histogenetic implications. Pathol Res Pract 2010;206:716-719. 168. Kaserovska D, Sima R, Michal M, et al. Carney complex: a clinicopathologic and molecular biological study of a sporadic case, including extracutaneous and cutaneous lesions and a novel mutation of the PRKAR1A gene.] Am Acad Dermatol 2008;61:80-87. 169. Rekhi B, Jambhekar NA. Morphologic spectrum, immuno-histochemical analysis, and clinical features of a series of granular cell tumors of soft tissues: a study from a tertiary referral cancer center. Ann Diagn PathoI2010;l4:162-167. 170. Hoshi N, Sugino T, Suzuki T.Regular expression of osteo-pontin in granular cell tumor; distinct feature among Schwannian cell tumors. Pathol Int 2005;55:484-490. 171. Coulon A, Milini S, Laban E, et al. Pathologic characteris-tics of the most frequent peripheral nerve tumors. Neuro-chirurgie 2009;55:454-458. 172. Zhu Y,Ghosh P, Charnay P, et al. Neurofibromas in NF 1: Schwann cell origin and role of tumor environment. Science 2002;296:920-922. 173. Takata M, Imai T, Hirone T.Factor -XIIIa- positive cells in nor-mal peripheral nerves and cutaneous neurofibromas of type-l neurofibromatosis. Am] DermatopatholI994;16:37-43. 174. Gabhane SK, Kotwal MN, Bobhate SK. Morphological spectrum of peripheral nerve sheath tumors: a series of 126 cases. Indian] Pathol Microbiol 2009;52:29-33. 175. Boyd KP, Korf BR, Theos A, Neurofibromatosis type 1.] Am Acad Dermatol 2009;61: 1-16. 176. Ferrer M, Schutz A, Gonzalez A, et al. Neurofibromatosis type 2: molecular and clinical analysis in Argen tine sporadic and familial cases. Neurosci Lett 2010;480:49-54. Epub 2010 Jun 8. 177. Carroll SL, Ratner N. How does the Schwann cell lineage form tumors in NF l?Glia 2008;56: 1590-1605. 178. Yang FC, Ingram DA, Chen S, et al. Neurofibromin-defi-cient Schwann cells secrete a potent migratory stimulus for Nfl+/-mast cells.] Clin Invest 2003; 112: 1851-1861. 179. Ferner RE. The neurofibromatoses. Pract Neurol 2010;10: 82-93. 180. Neff B, Welling DB, Akhmametyeva E. The molecular biol-ogy of vestibular Schwannomas: dissecting the pathogenic process at molecular level. Otol Neurotol 2006;27: 197-208. 181. Okada Y,You L, Giancotti FG. Shedding light on Merlin's wizardry. Trends Cell BioI 2007;17:222-229. 182. Ahmad Z, Brown CM, Patel AK, et al. Merlin knockdown in human schwannoma cells: clues to vestibular Schwannoma tumorigenesis. Otol Neurotol 2010;31 :460-466.183. Hadfield KD, Smith MJ, Urquhart JE, et al. Rates of loss of heterozygosity and mitotic recombination in NF2 schwanno-mas, sporadic vestibular schwannomas and schwannomato-sis schwannomas. Oncogene 2010;29:6216-6221. 184. Feany MB,AnthonyCD, FletcherCDM. Nerve sheath tumor with hybrid features of neurofibroma and schwannoma: a conceptual challenge. Histopathology 1998;32:405-410. 185. Macarenco AC, Macarenco RS. Intradermal monophasic hybrid schwannoma-perineurioma: a diagnostic challenge. Am] DermatopathoI2010;32:526-528. 186. Gershon TR, Shirazi A, Qin LX, et al. Enteric neural crest differentiation in ganglioneuromas implicates Hedgehog sig-naling in peripheral neuroblastic tumor pathogenesis. PLoS One 2009;16:e7491. 187. Mora J, Gerald WL. Origin of neuroblastic tumors: clues for future therapeutics. Expert Rev Mol Diagn 2004;4:293-302. 188. Takei H, Powell S. Novell immunohistochemical markers in the diagnosis of nonglial tumors of nervous system. Adv Anat Pathol 2010;17: 150-153. 189. Katz D, Lazar A, Lev D. Malignant peripheral nerve sheath tumor: the clinical implications of cellular signal-ing pathways. Expert Rev Mol Med 2009;11:e30-1-23. 190. Kraniak JM, Sun D, Mattingly RR, et al. The role of neu-rofibromin in N-Ras mediated AP-1 regulation in malig-nant peripheral nerve sheath tumors. Mol Cell Biochem 2010;344:267-276. 191. Woodruf JM. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. Am] Med Genet 1999; 26:23-30. 192. Hoang MP, Sinkre P,Albores-Saavedra J.Expression of Pro-tein gene product 9.5 in epithelioid and conventional malig-nant peripheral nerve sheath tumors. Arch Pathol Lab Med 2001; 125: 1321-1325. 193. Rosenberg AS, Langee CL, Stevenson GL, et al. Malignant peripheral nerve sheath tumor with perineurial differen-tiation: "malignant perineurioma". ] Cutan Pathol 2002; 29:362-367. 194. Yamaguchi U, Hasegawa T, Hirose T, et al. Low grade malig-nant peripheral nerve sheath tumour: varied cytological and histological patterns.] Clin Pathol 2003;56:826-830. 195. Tripthy K, Mallik R, MishraA, et al. A rare malignant triton tumor. Case Rep Neurol2010;2:69-73.  